Related Experiment Video
Updated: Apr 17, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism
Lauren A Barclay1, Thomas E Wales2, Thomas P Garner3
1Department of Pediatric Oncology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Abstract:
BCL-2 is a negative regulator of apoptosis implicated in homeostatic and pathologic cell survival. The canonical anti-apoptotic mechanism involves entrapment of activated BAX by a groove on BCL-2, preventing BAX homo-oligomerization and mitochondrial membrane poration. The BCL-2 BH4 domain also confers anti-apoptotic functionality, but the mechanism is unknown. We find that a synthetic α-helical BH4 domain binds to BAX with nanomolar affinity and independently inhibits the conformational activation of BAX. Hydrogen-deuterium exchange mass spectrometry demonstrated that the N-terminal conformational changes in BAX induced by a triggering BIM BH3 helix were suppressed by the BCL-2 BH4 helix. Structural analyses localized the BH4 interaction site to a groove formed by residues of α1, α1-α2 loop, and α2-α3 and α5-α6 hairpins on the BAX surface. These data reveal a previously unappreciated binding site for targeted inhibition of BAX and suggest that the BCL-2 BH4 domain may participate in apoptosis blockade by a noncanonical interaction mechanism.
Insights
The BCL-2 BH4 domain binds to BAX, inhibiting its activation and suggesting a new mechanism for blocking apoptosis. This discovery offers potential for targeted therapies against cell survival in diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- BCL-2 proteins regulate apoptosis, crucial for cell survival and disease.
- The canonical BCL-2 mechanism involves inhibiting BAX, but BH4 domain function is unclear.
Purpose of the Study:
- To elucidate the mechanism by which the BCL-2 BH4 domain inhibits apoptosis.
- To identify the binding site and interaction of BH4 with BAX.
Main Methods:
- Synthetic alpha-helical BH4 domain binding assays.
- Hydrogen-deuterium exchange mass spectrometry (HDX-MS).
- Structural analysis of BCL-2 BH4-BAX interactions.
Main Results:
- The BH4 domain binds BAX with nanomolar affinity, independently inhibiting its conformational activation.
- HDX-MS showed BH4 suppresses BAX N-terminal changes induced by BIM.
- Structural analysis identified a novel BH4 interaction site on the BAX surface.
Conclusions:
- The BCL-2 BH4 domain employs a noncanonical mechanism to block apoptosis by directly inhibiting BAX.
- A previously unrecognized binding site on BAX is revealed for targeted inhibition.
- Findings suggest new therapeutic strategies targeting BCL-2 interactions in cancer.
More Related Videos
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Apoptosis
Caspases
The JAK-STAT Signaling Pathway